State anxiety is associated with hormonal, cardiovascular, and sleep parameters in Finnish postmenopausal women
Maturitas · 2025
DOI: 10.1016/j.maturitas.2025.108266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maturitas, 2025. Verfasst von Ville Rimpilä und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Research Center, University of Turku, Turku, Finland. Electronic address: ville.rimpila@utu.fi. Hauptthemen laut MEDLINE: Postmenopause, Anxiety, Depression, Blood Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Turku University Hospital, Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö ry, Hengityssairauksien Tutkimussäätiö.
Abstract (Originalsprache)
OBJECTIVE: To investigate how a range of variables, both physiological (sleep architecture, serum follicle-stimulating hormone (S-FSH), anthropometric and blood pressure measures) and non-physiological (stressful life events, education), are associated with symptoms of distress, anxiety, and depression from premenopause to postmenopause and at postmenopause. METHODS: We recruited 64 women (ages 45-47). Data were derived from an in-house questionnaire, the Brief Symptom Inventory, State-Trait Anxiety Inventory, Beck Depression Inventory, a sleep questionnaire, physiological measurements, and polysomnography at baseline and at ten-year follow-up. RESULTS: During the follow-up, an increase in weight was associated with an increase in anxiety as recorded by the Brief Symptom Inventory (p = 0.012, R2 = 0.117). Cross-sectionally, at postmenopause, state anxiety was associated with an increase in blood pressure and S-FSH, delayed REM sleep, and the use of menopausal hormone therapy (pSTAI-S < 0.001, R2 = 0.343). Distress and depressive symptoms were associated with stressful life events and a lower level of education but also with an increase in diastolic blood pressure and use of hormone therapy (pBSI < 0.001, R2 = 0.328 and pBDI < 0.001, R2 = 0.312). Sleep disruptions were associated with psychological symptoms but vasomotor symptoms were not. CONCLUSIONS: The change in psychological symptoms during the follow-up was modest. At postmenopause, distress and depressive symptoms were associated with a range of physiological and non-physiological parameters, but state anxiety only with physiological parameters. At postmenopause, psychological symptoms were more sensitive to sleep disruptions than were vasomotor symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sleep Research Center, University of Turku, Turku, Finland. Electronic address: ville.rimpila@utu.fi.
- Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.
- Sleep Research Center, University of Turku, Turku, Finland; Department of Psychology and Speech-Language Pathology and Turku Brain and Mind Center, University of Turku, Turku, Finland; Department of Cognitive Neuroscien…
- Sleep Research Center, University of Turku, Turku, Finland; Division of Medicine, Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland.
Förderung
- Turku University Hospital
- Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö ry
- Hengityssairauksien Tutkimussäätiö
Zitieren
APA
Rimpilä, V., Vahlberg, T., Valli, K., & Saaresranta, T. (2025). State anxiety is associated with hormonal, cardiovascular, and sleep parameters in Finnish postmenopausal women. Maturitas. https://doi.org/10.1016/j.maturitas.2025.108266
Vancouver
Rimpilä V, Vahlberg T, Valli K, Saaresranta T. State anxiety is associated with hormonal, cardiovascular, and sleep parameters in Finnish postmenopausal women. Maturitas. 2025. doi:10.1016/j.maturitas.2025.108266
BibTeX
@article{Rimpil2025,
author = {Rimpilä, Ville and Vahlberg, Tero and Valli, Katja and Saaresranta, Tarja},
title = {State anxiety is associated with hormonal, cardiovascular, and sleep parameters in Finnish postmenopausal women},
journal = {Maturitas},
year = {2025},
doi = {10.1016/j.maturitas.2025.108266}
}
EUVIMED